Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts

Oct 02 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US Advisory Panel Leaves No Room For Doubt: Oral Phenylephrine Ineffective As Nasal Decongestant

Sep 13 2023

Fast Start To Oral Phenylephrine Efficacy Complaints As US FDA Considers 'Any Action'

Sep 14 2023

US FDA Finds Phenylephrine Ineffective As Nasal Decongestant, Looks At Removing From Monograph

Sep 10 2023

Xlear Admits Referencing Research, Avers Studies Support Saline Nasal Spray’s COVID-19 Efficacy

Dec 23 2021

Additional Topics

International United States US States Ad Campaigns FDA OTC Drugs Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Consumer Advisory Committees Ingredients Manufacturing Retail Legal Issues

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window